Spyre Therapeutics CFO Scott L. Burrows disposes of USD 1.85 million in common shares

• Spyre Therapeutics CFO Scott L. Burrows cut his direct stake to 79,762 common shares.
• Sold 17,500 shares on Sep. 30 at a weighted average price of $89.89.
• Disposed of 7,500 shares on Oct. 1, including sales at weighted average prices from $89.07 to $93.57.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Spyre Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001636282-26-000117), on October 02, 2026, and is solely responsible for the information contained therein.